Mitochondrial Dysfunction in Neurodegenerative Disease Mechanisms

Mitochondria are pivotal to neuronal health, supplying the bulk of cellular ATP, regulating calcium homeostasis and orchestrating apoptotic signalling. In neurodegenerative diseases such as Parkinson’s, Alzheimer’s and multiple sclerosis, a convergence of mitochondrial bioenergetic failure, oxidative stress and impaired organelle quality control drives progressive neuronal loss. Deficits in respiratory chain complexes precipitate energy shortfalls, while excessive production of reactive oxygen species exacerbates oxidative damage to proteins, lipids and mitochondrial DNA. Disturbed mitochondrial dynamics and defective mitophagy hinder the removal of damaged organelles, further compromising neuronal survival. Aberrant calcium handling and opening of the mitochondrial permeability transition pore amplify excitotoxic injuries, and inflammation-induced alterations in microglial mitochondrial function sustain chronic neuroinflammation. Together, these interconnected processes underpin a complex pathophysiological landscape with global implications for diagnosis and therapy, highlighting mitochondrial pathways as promising targets for neuroprotective strategies.

Research from Nature Portfolio

Recent studies have illuminated the role of mitochondrial complex I in microglial activation, demonstrating that elevated complex I activity drives reverse electron transport and sparks sustained production of reactive oxygen species. Pharmacological inhibition of complex I in pro-inflammatory microglia attenuates neurotoxic damage and improves outcomes in animal models, suggesting that targeted modulation of microglial metabolism may curb chronic central nervous system inflammation.

Complementary work has revealed that neuroinflammatory lesions induce widespread axonal energy deficits through both impaired electron transport chain function and an upstream depletion of key tricarboxylic acid cycle enzymes. Restoration of individual TCA cycle components via viral overexpression ameliorates axonal ATP shortages in experimental lesions, pointing to enzyme‐specific therapies to rescue neuronal energy homeostasis in demyelinating diseases.

Mitochondrial Dysfunction in Neurodegenerative Disease Mechanisms publication trend

The graph below shows the total number of articles in mitochondrial dysfunction in neurodegenerative disease mechanisms across all publications each year (not limited to Nature Index journals).

Technical terms

Microglia: Resident immune cells of the central nervous system that modulate neuroinflammation and neuronal support.

Mitochondrial complex I: First enzyme of the electron transport chain that transfers electrons from NADH to ubiquinone, crucial for ATP production.

Reverse electron transport: Electron flow from ubiquinol back to complex I, often generating reactive oxygen species under high membrane potential.

Reactive oxygen species (ROS): Chemically reactive molecules derived from oxygen that can damage cellular macromolecules.

Tricarboxylic acid (TCA) cycle: Central metabolic pathway in mitochondria that generates reducing equivalents for oxidative phosphorylation.

Mitochondrial permeability transition pore (mPTP): High-conductance channel whose opening under stress disrupts membrane potential and can trigger cell death.

References

1. Mitochondrial complex I activity in microglia sustains neuroinflammation. Nature (2024).
2. Targeting the TCA cycle can ameliorate widespread axonal energy deficiency in neuroinflammatory lesions. Nature Metabolism (2023).
3. Excitotoxicity, calcium and mitochondria: a triad in synaptic neurodegeneration. Translational Neurodegeneration (2022).
4. Mitochondrial Quality Control in Neurodegenerative Diseases: Focus on Parkinson's Disease and Huntington's Disease. Frontiers in Neuroscience (2018).